搜索临床试验以:6R-BH4
总计120个结果
-
Johns Hopkins UniversityBioMarin Pharmaceutical终止
-
Vanderbilt UniversityNational Institutes of Health (NIH); BioMarin Pharmaceutical完全的
-
BioMarin Pharmaceutical完全的
-
Emory UniversityNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Astellas Pharma Global Development, Inc.撤销实体瘤 | 表皮生长因子受体 (EGFR) 突变
-
University Tunis El Manar完全的
-
Emory UniversityBioMarin Pharmaceutical; Atlanta Clinical and Translational Science Institute完全的
-
Taipei Veterans General Hospital, TaiwanBioMarin Pharmaceutical未知多环芳烃缺乏症 | Pku 苯丙酮尿症
-
Children's Hospital of Philadelphia完全的
-
Rush University Medical CenterCongressionally Directed Medical Research Programs尚未招聘
-
IRCCS San RaffaeleServier完全的
-
D. Walter WrayUS Department of Veterans Affairs招聘中
-
Merck KGaA, Darmstadt, GermanySmerud Medical Research International AS; Merck Serono Norway完全的
-
Northwestern UniversityNational Cancer Institute (NCI); Gateway for Cancer Research终止
-
Isofol Medical AB完全的
-
BioMarin Pharmaceutical完全的
-
Mahidol UniversityUniversity of Texas; University of Wuerzburg完全的
-
BioMarin Pharmaceutical完全的苯丙酮尿症 (PKU) 或四氢生物蝶呤 (BH4) 缺乏症导致的高苯丙氨酸血症 (HPA)瑞典, 法国, 意大利, 西班牙, 德国, 荷兰, 奥地利, 斯洛伐克, 葡萄牙